Life Technologies completes previously announced acquisition of BioTrove

Download PDF Copy

Dec 16 2009

Life Technologies Corporation (NASDAQ:LIFE), a provider of innovative life science solutions, today announced that it has completed the previously announced acquisition of BioTrove, Inc. for an undisclosed amount.

BioTrove’s primary technology is the OpenArray^® platform, a high throughput gene expression and genotyping analysis system based on a flexible array format that enables researchers to perform more than 3,000 PCR genotyping or qPCR gene expression assays at a time.

As previously announced, Life Technologies does not expect this transaction to have a material effect on its financials in fiscal year 2009.

http://www.lifetechnologies.com/

Posted in:

Comments (0)

Download PDF Copy

Suggested Reading

Cancer hijacks embryonic gene editors to fuel growth

Psoriasis-linked gene mutation may also play a surprising role in gut health

Study reveals how a microglial mutation increases risk for Alzheimer's disease

Discovery explains why women face higher risk of Alzheimer’s and multiple sclerosis

HMGN1 gene linked to heart problems in people with Down syndrome

New gene-editing method can correct many disease-causing mutations in mammalian cells

International experts publish guidelines on the administration of gene therapy for hereditary hearing loss

Runx1 overexpression triggers early intervertebral disc degeneration

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.

Post a new comment

(Logout)

Post

Sign in to keep reading

We're committed to providing free access to quality science. By registering and providing insight into your preferences you're joining a community of over 1m science interested individuals and help us to provide you with insightful content whilst keeping our service free.